Skip to main content

Advertisement

Table 1 Disease and steroid treatment characteristics of the patient group

From: Psychosocial and cognitive function in children with nephrotic syndrome: association with disease and treatment variables

  Patients
  n (%)
Severity of disease Mild 14 (34.1)
  Moderate 16 (39.0)
  Severe 11 (26.8)
   Median IQR
Age at diagnosis (ys) 3.50 1.90
Duration of illness (ys) 3.00 4.60
Total duration of steroid medication (months) 31.00 44.00
Present methylprednisolone dose (mg/kg/day)* 0.16 0.19
Duration of present dose (days)** 38.00 99.00
  1. IQR, Interquartile range (75th-25th percentile).
  2. *18/41 were on methylprednisolone and 23/41 on prednisolone treatment. The dose was homogenized using the appropriate equivalence.
  3. ** The steroid dose was often changed for better outcome.